DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Deferiproneis the generic ingredient in two branded drugs marketed by Chiesi and Taro Pharm Inds Ltd, and is included in four NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
Deferiprone has forty-three patent family members in twenty-five countries.
There are four drug master file entries for deferiprone. Three suppliers are listed for this compound.
Summary for deferiprone
|Drug Master File Entries:||4|
|Suppliers / Packagers:||3|
|Bulk Api Vendors:||96|
|Formulation / Manufacturing:||see details|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for deferiprone|
|DailyMed Link:||deferiprone at DailyMed|
Recent Clinical Trials for deferiprone
Identify potential brand extensions & 505(b)(2) entrants
|First Affiliated Hospital of Fujian Medical University||Early Phase 1|
|David Hasan||Phase 2|
|Ministry of Health, France||Phase 2/Phase 3|
Pharmacology for deferiprone
|Drug Class||Iron Chelator |
|Mechanism of Action||Iron Chelating Activity |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Taro Pharm Inds Ltd||DEFERIPRONE||deferiprone||TABLET;ORAL||208800-001||Feb 8, 2019||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Chiesi||FERRIPROX||deferiprone||TABLET;ORAL||021825-001||Oct 14, 2011||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|Chiesi||FERRIPROX||deferiprone||TABLET;ORAL||021825-002||Jul 25, 2019||RX||Yes||No||Start Trial||Start Trial||Start Trial|
|Chiesi||FERRIPROX||deferiprone||SOLUTION;ORAL||208030-002||Apr 20, 2018||RX||Yes||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.